Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Other Comprehensive Loss	Total
Balance at Jun. 30, 2021	$ 26,498	$ 26,982,052	$ (21,461,888)	$ (119,577)	$ 5,427,085
Balance (in shares) at Jun. 30, 2021	26,498,215
Fair value of vested stock options		424,450			424,450
Fair value of vested restricted common stock	$ 293	446,140			446,433
Fair value of vested restricted common stock (in shares)	293,211
Repurchase of common stock	$ (34)	(82,019)			(82,053)
Repurchase of common stock (in shares)	(33,402)
Common stock issued upon exercise of stock options	$ 194	97,494			97,688
Common stock issued upon exercise of stock options (in shares)	192,820
Common stock issued upon exercise of warrants	$ 50	59,450			59,500
Common stock issued upon exercise of warrants (in shares)	50,000
Net income (loss) for the period			(1,194,117)		(1,194,117)
Foreign currency translation				(1,181)	(1,181)
Balance at Mar. 31, 2022	$ 27,001	27,927,567	(22,656,005)	(120,758)	5,177,805
Balance (in shares) at Mar. 31, 2022	27,000,844
Balance at Jun. 30, 2021	$ 26,498	26,982,052	(21,461,888)	(119,577)	5,427,085
Balance (in shares) at Jun. 30, 2021	26,498,215
Balance at Jun. 30, 2022	$ 27,076	28,072,855	(23,094,272)	(121,941)	4,883,718
Balance (in shares) at Jun. 30, 2022	27,075,648
Balance at Dec. 31, 2021	$ 26,817	27,475,741	(22,315,475)	(122,367)	5,064,716
Balance (in shares) at Dec. 31, 2021	26,817,056
Fair value of vested stock options		296,782			296,782
Fair value of vested restricted common stock	$ 42	102,410			102,452
Fair value of vested restricted common stock (in shares)	42,214
Repurchase of common stock	$ (6)	(14,235)			(14,241)
Repurchase of common stock (in shares)	(6,086)
Common stock issued upon exercise of stock options	$ 148	66,869			67,017
Common stock issued upon exercise of stock options (in shares)	147,660
Net income (loss) for the period			(340,530)		(340,530)
Foreign currency translation				1,609	1,609
Balance at Mar. 31, 2022	$ 27,001	27,927,567	(22,656,005)	(120,758)	5,177,805
Balance (in shares) at Mar. 31, 2022	27,000,844
Balance at Jun. 30, 2022	$ 27,076	28,072,855	(23,094,272)	(121,941)	4,883,718
Balance (in shares) at Jun. 30, 2022	27,075,648
Fair value of vested stock options		338,973			338,973
Fair value of vested restricted common stock	$ 2,355	923,195			925,550
Fair value of vested restricted common stock (in shares)	2,354,834
Fair value of vested unrestricted common stock	$ 36	68,236			68,272
Fair value of vested unrestricted common stock (in shares)	36,509
Repurchase of common stock	$ (38)	(74,518)			(74,556)
Repurchase of common stock (in shares)	(38,585)
Forfeited restricted common stock	$ (65)	65
Forfeited restricted common stock (in shares)	(65,165)
Common stock issued upon exercise of stock options	$ 137	57,363			$ 57,500
Common stock issued upon exercise of stock options (in shares)	137,523				307,298
Net income (loss) for the period			195,877		$ 195,877
Foreign currency translation				(2,801)	(2,801)
Balance at Mar. 31, 2023	$ 29,501	29,386,169	(22,898,395)	(124,742)	6,392,533
Balance (in shares) at Mar. 31, 2023	29,500,764
Balance at Dec. 31, 2022	$ 29,155	28,874,383	(23,135,237)	(120,593)	5,647,708
Balance (in shares) at Dec. 31, 2022	29,154,737
Fair value of vested stock options		37,236			37,236
Fair value of vested restricted common stock	$ 333	442,890			443,223
Fair value of vested restricted common stock (in shares)	332,500
Repurchase of common stock	$ (13)	(25,814)			(25,827)
Repurchase of common stock (in shares)	(12,785)
Forfeited restricted common stock	$ (65)	65
Forfeited restricted common stock (in shares)	(65,165)
Common stock issued upon exercise of stock options	$ 91	57,409			57,500
Common stock issued upon exercise of stock options (in shares)	91,477
Net income (loss) for the period			236,842		236,842
Foreign currency translation				(4,149)	(4,149)
Balance at Mar. 31, 2023	$ 29,501	$ 29,386,169	$ (22,898,395)	$ (124,742)	$ 6,392,533
Balance (in shares) at Mar. 31, 2023	29,500,764